| 11939630 |
Fluorescent PCR method for detecting HLA-B*15:02 allele and specific primer probe combination thereof |
Penggao Dai, Zihua Zhong, Hao Wang, Zhiye Cai, Lei Meng |
2024-03-26 |
|
| 11897864 |
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases |
Milan Bruncko, Hong Ding, George A. Doherty, Steven W. Elmore, Lisa A. Hasvold +11 more |
2024-02-13 |
$820,337,000 |
| 11786519 |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
George A. Doherty, Xilu Wang, Zhi-Fu Tao, Milan Bruncko, Aaron R. Kunzer +7 more |
2023-10-17 |
$748,131,000 |
| 10633379 |
Bromodomain inhibitors |
Lisa A. Hasvold, Dachun Liu, Keith F. McDaniel, John K. Pratt, George S. Sheppard |
2020-04-28 |
$741,076,000 |
| 10131657 |
Bromodomain inhibitors |
Yujia Dai, Steven D. Fidanze, Lisa A. Hasvold, James H. Holms, Dachun Liu +4 more |
2018-11-20 |
$295,346,000 |
| 10085985 |
Bromodomain inhibitors |
Andrew Bogdan, Warren M. Kati, Keith F. McDaniel, Chang H. Park, George S. Sheppard |
2018-10-02 |
$475,686,000 |
| 10035800 |
Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors |
Steven D. Fidanze, Dauchun Liu, Robert A. Mantei, Keith F. McDaniel, John K. Pratt +7 more |
2018-07-31 |
$1,048,772,000 |
| 9994581 |
Bromodomain inhibitors |
Robin Frey, Todd M. Hansen, Dachun Liu, William J. McClellan, Keith F. McDaniel +2 more |
2018-06-12 |
$512,591,000 |
| 9957263 |
Bromodomain inhibitors |
Yujia Dai, Steven D. Fidanze, Lisa A. Hasvold, James H. Holms, Dachun Liu +4 more |
2018-05-01 |
$212,650,000 |
| 9877958 |
Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases |
George A. Doherty, Xilu Wang, Zhi-Fu Tao, Milan Bruncko, Aaron R. Kunzer +7 more |
2018-01-30 |
$149,887,000 |
| 9844547 |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
George A. Doherty, Xilu Wang, Zhi-Fu Tao, Milan Bruncko, Aaron R. Kunzer +7 more |
2017-12-19 |
$630,611,000 |
| 9776990 |
Isoindolone derivatives |
John K. Pratt, Dachun Liu, Chang H. Park, George S. Sheppard, Lisa A. Hasvold |
2017-10-03 |
$330,271,000 |
| 9561231 |
Pyridinone and pyridazinone derivatives |
Robert Hubbard, Chang H. Park, Chaohong Sun, Keith F. McDaniel, John K. Pratt +5 more |
2017-02-07 |
$154,932,000 |
| 9428514 |
Bromodomain inhibitors |
Andrew Bogdan, Warren M. Kati, Keith F. McDaniel, Chang H. Park, George S. Sheppard |
2016-08-30 |
$749,415,000 |
| 9359296 |
7-substituted indole Mcl-1 inhibitors |
Xilu Wang, Xiaohong Song, Steven W. Elmore, Milan Bruncko, David J. Madar +4 more |
2016-06-07 |
$166,684,000 |
| 9321764 |
Dihydro-pyrrolopyridinone inhibitors |
John K. Pratt, Lisa A. Hasvold, Dachun Liu, Yujia Dai, Steven D. Fidanze +5 more |
2016-04-26 |
$170,981,000 |
| 9303025 |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
Milan Bruncko, Hong Ding, George A. Doherty, Steven W. Elmore, Lisa A. Hasvold +11 more |
2016-04-05 |
$168,990,000 |
| 9296741 |
Bromodomain inhibitors |
John K. Pratt, Keith F. McDaniel, Yujia Dai, Steven D. Fidanze, Lisa A. Hasvold +7 more |
2016-03-29 |
$208,660,000 |
| 9266877 |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
George A. Doherty, Xilu Wang, Zhi-Fu Tao, Milan Bruncko, Aaron R. Kunzer +7 more |
2016-02-23 |
$107,573,000 |
| 9227963 |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
George A. Doherty, Xilu Wang, Zhi-Fu Tao, Milan Bruncko, Aaron R. Kunzer +7 more |
2016-01-05 |
$107,907,000 |
| 9174982 |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
Milan Bruncko, Hong Ding, George A. Doherty, Steven W. Elmore, Lisa A. Hasvold +11 more |
2015-11-03 |
$135,647,000 |
| 9125913 |
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
Milan Bruncko, Hong Ding, George A. Doherty, Steven W. Elmore, Lisa A. Hasvold +14 more |
2015-09-08 |
$486,264,000 |
| 9072748 |
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
Milan Bruncko, Hong Ding, George A. Doherty, Steven W. Elmore, Lisa A. Hasvold +14 more |
2015-07-07 |
$112,787,000 |
| 9073855 |
BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
George A. Doherty, Steven W. Elmore, Lisa A. Hasvold, Laura Hexamer, Robert A. Mantei +7 more |
2015-07-07 |
$112,787,000 |
| 9045420 |
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
George A. Doherty, Steven W. Elmore, Lisa A. Hasvold, Laura Hexamer, Robert A. Mantei +7 more |
2015-06-02 |
$71,334,000 |
